Mar 14, 2024
1:20
For every 20 shares held, investors received 1.
The split itself did not change the total investment value.
Outlook Therapeutics, Inc. (GETTEX:41O) operates in the Pharmaceuticals: major industry.
Outlook Therapeutics, Inc. company overviewOutlook Therapeutics, Inc.'s most recent stock split was on March 14, 2024. It was a 1-for-20 reverse split, so shareholders received 1 share for every 20 they held.
Outlook Therapeutics, Inc. (GETTEX:41O) has split its stock 2 times: a 1-for-8 reverse split on March 18, 2019 and a 1-for-20 reverse split on March 14, 2024.
Outlook Therapeutics, Inc. has split its stock 2 times. This history records 2 reverse splits between March 18, 2019 and March 14, 2024.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Outlook Therapeutics, Inc.'s 1-for-20 reverse split on March 14, 2024, every 20 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Outlook Therapeutics, Inc. has not announced a new split in our records. Its most recent split was on March 14, 2024, 2 years ago. Companies announce splits in advance, and any new GETTEX:41O split will appear on this page.